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Interferon-g (IFN-g) promotes a population of T-bet+
CXCR3+ regulatory T (Treg) cells that limit T helper 1
(Th1) cell-mediated pathology. Our studies demon-
strate that interleukin-27 (IL-27) also promoted
expression of T-bet and CXCR3 in Treg cells. During
infection with Toxoplasma gondii, a similar popula-
tion emerged that limited T cell responses and was
dependent on IFN-g in the periphery but on IL-27 at
mucosal sites. Transfer of Treg cells ameliorated
the infection-induced pathology observed in Il27/
mice, and this was dependent on their ability to
produce IL-10. Microarray analysis revealed that
Treg cells exposed to either IFN-g or IL-27 have
distinct transcriptional profiles. Thus, IFN-g and
IL-27 have different roles in Treg cell biology and
IL-27 is a key cytokine that promotes the develop-
ment of Treg cells specialized to control Th1 cell-
mediated immunity at local sites of inflammation.
INTRODUCTION
IL-27 is a member of the IL-6 and IL-12 family of cytokines. Early
studies described it as an inducer of the T helper 1 (Th1) cell-
associated transcription factor T-bet, which enhances Th1
differentiation (reviewed in Hall et al., 2012). However, IL-27 is
also an antagonist of inflammation associated with Th1, Th2,
and Th17 cell responses in multiple settings (Stumhofer and
Hunter, 2008) and the regulatory properties of IL-27 can be ex-
plained in part by its ability to limit IL-2 production, antagonize
Th2 and Th17 cell responses, and promote T cell production of
IL-10. However, questions remain about the mechanisms usedImby IL-27 to limit immune pathology associated with Th1 cell
responses (reviewed in Stumhofer and Hunter, 2008; Yoshida
and Miyazaki, 2008).
CD4+ T cells that express the transcription factor Foxp3 (Treg
cells) are an important means of immune suppression. Recent
studies have demonstrated that during inflammation, special-
ized populations of Treg cells emerge that express transcrip-
tional profiles similar to their effector cell counterparts (Esposito
et al., 2010; Fujimoto et al., 2011; Koch et al., 2009). It has been
suggested that this heterogeneity allows for regulation of
specific types of immunity. For example, Treg cell expression
of STAT3 is critical for limiting Th17 cell responses (Chaudhry
et al., 2009), whereas expression of IRF4 allows control of Th2
cells (Zheng et al., 2009). During infections dominated by Th1
cells, Treg cells express Tbx21 and Cxcr3, genes associated
with the presence of IFN-g, and expression of T-bet is required
for their survival and proliferation (Koch et al., 2009). Whereas
IFN-g has been implicated in the development of this specialized
Treg cell population, whether other environmental cues influence
this program is unclear.
A subset of natural Treg (nTreg) cells expresses high levels of
the IL-27Ra (Villarino et al., 2005). Paradoxically, there are
reports that IL-27 is a direct antagonist of Treg cell conversion
(Cox et al., 2011; Huber et al., 2008; Neufert et al., 2007;
Stumhofer et al., 2007). The data presented here reveal that,
contrary to these reports, IL-27 does not limit Treg cells and
directly promotes Treg cell expression of T-bet and CXCR3. In
mice challenged with T. gondii, or other intracellular pathogens,
a population of Treg cells emerged that expressed T-bet,
CXCR3, and IL-10 and limited T effector responses. In mice
that lack IL-27, this population is reduced at primary sites of
infection but not at peripheral sites, such as in the spleen, where
IFN-g had a more prominent role. However, transcriptional
profiling highlighted that IL-27 appeared to have a more
dominant impact than IFN-g on Treg cell expression ofmunity 37, 511–523, September 21, 2012 ª2012 Elsevier Inc. 511
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IL-27 Promotes Th1 Treg Cellsimmunosuppressive genes such as Il10. Together, these studies
identify distinct roles for IL-27 and IFN-g in driving the T-bet+
subset of Treg cells that are specialized to control regional
pathology during Th1 cell responses.
RESULTS
IL-27 Promotes the Expression of T-bet and CXCR3 in
Inducible Treg Cells and Natural Treg Cells
Although previous studies have demonstrated that 30%–40%
of nTreg cells express the IL-27Ra, it was unclear whether this
receptor was functional in Foxp3+ CD4+ T cells. In this study,
we define nTreg cells as Foxp3+ CD4+ T cells isolated from
mice and ‘‘inducible’’ Treg (iTreg) cells as Foxp3+ CD4+ Treg
cells generated from Foxp3 CD25 precursors in vitro. To
address whether nTreg cells respond to IL-27, we incubated
naive CD25+ T cells or Foxp3GFP+ cells with IL-27. Whereas
unstimulated cells had negligible amounts of pSTAT1 or
pSTAT3, IL-27 induced pSTAT1 and pSTAT3 in 30%–40% of
nTreg cells (Figure 1A). Similarly, IL-27 induced pSTAT1 and
pSTAT3 in 50%–70% of iTreg cells (Figure 1B). It is notable
that in Treg cells, IFN-g and IL-10 also activate STAT1 and
STAT3, respectively, but thiswas less thanwith IL-27 (Figure S1A
available online). It is also relevant to note that previous reports
have suggested that IL-27 antagonizes iTreg cell development
(Huber et al., 2008; Neufert et al., 2007; Stumhofer et al., 2007;
Cox et al., 2011), and in our experiments, the frequency of
Treg cells were initially reduced in the presence of IL-27, but
Treg cells were generated and their numbers increased over
time (Figures S1B and S1C). Together, these data suggest that
existing and emerging Treg cell responses can be influenced
by IL-27 and that IL-27 can actually promote Treg cell expansion.
Because IL-27 induces the expression of T-bet in effector
CD4+ T cells, studies were performed to determine whether
IL-27 had a similar effect on Treg cells. When naive Foxp3
CD4+ T cells were used to generate iTreg cells, those cultured
in the presence of IL-27 expressed elevated levels of T-bet (Fig-
ure S1D). When Treg cells were differentiated in the presence of
IL-27 plus a-IL-4 and a-IFN-g (neutral conditions), it still
promoted Treg cell expression of T-bet (Figure 1C). Thus, inde-
pendent of its ability to promote IFN-g, IL-27 promotes Treg
cell expression of T-bet. It is notable that long-term TCR
signaling was associated with the eventual upregulation of
T-bet in cultures of Treg cells, although the highest amounts
of T-bet were always observed in the presence of IL-27
(Figure S1E).
Previous studies established that activation of T-bet in Treg
cells promotes expression of CXCR3 (Koch et al., 2009), a che-
mokine receptor involved in lymphocyte migration during Th1
cell responses (Lord et al., 2005). When iTreg cells were gener-
ated with IL-27, there was a consistent 4- to 5-fold increase in
CXCR3 levels and nTreg cells incubated with IL-27 for 24 to
48 hr expressed high levels of T-bet and CXCR3 (Figure 1C).
Similarly, although iTreg cells stimulated with PMA and ionomy-
cin did not produce IL-10 or IFN-g, those generated in the pres-
ence of IL-27 expressed IFN-g and IL-10 (Figure 1D). Together,
these data demonstrate that IL-27 promotes cytokine produc-
tion by Treg cells and influences their proliferation, survival,
and chemokine receptor expression.512 Immunity 37, 511–523, September 21, 2012 ª2012 Elsevier Inc.IL-27-Driven Expansion of CXCR3+ Treg Cells Requires
STAT1 and T-bet
Because IL-27 activates STAT1 and STAT3, experiments were
performed to determine which pathway contributed to the
upregulation of T-bet and CXCR3 in iTreg cells. As noted earlier,
addition of IL-27 to the cultures led to the induction of T-bet
in 15%–30% of the iTreg cells, and a modest but consistent
increase in T-bet was observed in the Stat3/ CD4+ T cells (Fig-
ure S1F). However, in the Stat1/ Treg cell cultures, IL-27 did
not induce T-bet (Figure 1E). In addition to T-bet, Eomesodermin
(Eomes) has been shown to promote CXCR3 expression
(Intlekofer et al., 2008), and polyclonal expansion of naive cells
CD4+ T cells in the presence of IL-27 led to increased levels of
Eomes and T-bet, but in iTreg cells, IL-27 did not promote Eomes
(Figure S1G). This finding is consistent with the idea that TGF-b
(required for the iTreg cell cultures) suppresses Eomes but not
T-bet (Narayanan et al., 2010). Moreover, Treg cells generated
with IL-27 from Eomes/ T cells showed upregulation of
CXCR3, similar to wild-type (WT) Treg cells (Figure 1F), whereas
Tbx21/ iTreg cells had impaired upregulation of CXCR3 (Fig-
ure 1F). These data suggest a model in which the ability of IL-27
to activate STAT1 drives T-bet andCXCR3 expression in a subset
of iTreg cells.
IL-27 Treatment Increases TregCell Expression of T-bet
and CXCR3 In Vivo
To assess the effects of IL-27 on the phenotype of Treg
cells in vivo, Chen et al. (2005) used hydrodynamic gene delivery
to administer DNA plasmid ‘‘minicircles’’ that express IL-27
(IL-27MC). Mice that received IL-27MC or GFP vector-only
controls were sacrificed after 4 weeks for analysis of their
T cell populations. No pathology was noted in either experi-
mental group (data not shown), and although there was
increased cellularity associated with IL-27MC (Figure S2A),
there was no decrease in Treg cell frequency (Figure S2B).
Although total splenic CD4+ T cells from mice given IL-27MC
had higher amounts of T-bet (Figure S2C), further analysis
revealed that, consistent with the ability of IL-27 to promote a
population of T-bet+ CXCR3+ Treg cells in vitro, only the Foxp3+
Treg cell population had higher T-bet and CXCR3 expression
(Figures 2A–2D).
Infection with T. gondii Induces an Immunosuppressive
T-bet+ CXCR3+ Treg Cell Population
Challenge with T. gondii results in the development of CD4+
effector T cells that produce IFN-g and IL-10 (Jankovic et al.,
2007; Stumhofer et al., 2007). Analysis of Treg cells from infected
mice after restimulation with PMA and ionomycin and/or directly
ex-vivo from Vert-X IL-10-eGFP reporter mice revealed that
these cells were also a source of IFN-g and IL-10 (Figures 3A
and 3B). After restimulation, a portion of these T. gondii-induced
IL-10+ Treg cells coexpressed IFN-g as well as T-bet and CXCR3
(Figures 3C–3E). Further analysis of BrdU incorporation and
Ki-67 expression revealed that infection promoted proliferation
of these cells (Figures S3A and S3B). The appearance of
CXCR3+ T-bet+ Treg cells coincided with the emergence of
a population of cells that produced IL-27p28. Although conven-
tional DCs (CD11chi Class-II+) produced IL-12p40 in the spleen
and the lamina propria (LP) population, IL-27p28 production
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Figure 1. IL-27 Treatment of TregCells InducesSTAT1 andSTAT3 Phosphorylation and the Expansion of a STAT1-Dependent T-bet+ CXCR3+
Population
(A and B) Natural Treg (nTreg) cells harvested from naive mice (A) and inducible Treg (iTreg) cells generated in vitro (as described in the Experimental Procedures)
were stimulated with IL-27 or media alone (B), and phosphorylated STAT1 and STAT3 were measured by flow cytometry. Plots depict the mean percentage ±
standard error of the mean (SEM) of Treg cells (gated on LIVE/DEAD Fixable Aqua Dead Cell marker, CD4+, Foxp3+ cells) expressing pSTAT1 or pSTAT3.
(C) nTreg cells or iTreg cells were cultured in the presence of neutralizing antibodies to IFN-g and IL-4 (neutral conditions) and in the presence or absence of IL-27.
After 48 hr of culture, the expression of T-bet and CXCR3wasmeasured by flow cytometry. Plots depict the percentage of positive Treg cells (number inside gate)
and the geometric mean channel fluorescence (MFI) to the left of the gate.
(D) iTreg cells were cultured in the presence or absence of IL-27 for 72 hr and subsequently restimulated with PMA and ionomycin in the presence of BFA and
monensin Golgi inhibitors for 5 hr. The production of IFN-g and IL-10 by iTreg cells was measured by flow cytometry.
(E) iTreg cells were generated fromwild-type (WT) and Stat1/ deficient T cells in the presence or absence of IL-27 for 72 hr. Plots depict the mean percentage ±
SEM of Treg cells that expressed T-bet or CXCR3.
(F) iTreg cells were generated from WT, Tbx21/, and CD4-Cre x Eomesfl/fl mice in the presence or absence of IL-27 for 48 hr. The percentage (inside plot) and
MFI (outside plot) of Treg cells expressing CXCR3 was measured by flow cytometry. All plots are representative of three independent experiments with three
replicates per group. See also Figure S1.
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IL-27 Promotes Th1 Treg Cellswas the highest in the LP and was made by monocytes and
macrophages (CD11b+ CD11cLo) (Figure 3F).
To determine whether Treg cells contributed to the control of
the Th1 cell response during toxoplasmosis, we used DEREG
mice to deplete Treg cells and performed analysis of effector
cell proliferation and cytokine production. This treatment re-
sulted in 70% loss of Treg cells (Figure S3C) and an increased
frequency of Ki-67+ effector CD4+ and CD8+ T cells (Figure S3D).
This effect was accompanied by increased T-bet and IFN-gImexpression in CD4+ and CD8+ T cells in response to soluble
Toxoplasma antigen (STAg) (Figure 3G; Figure S3E). Thus, the
Treg cells present in infected mice limited the Th1 effector cell
response to T. gondii.
The Role of IL-27 in Regulating Treg Cell Populations
during Multiple Th1 Cell Infections
To determine whether IL-27 was involved in generating Treg cell
heterogeneity during Th1 responses, we challenged Il27/micemunity 37, 511–523, September 21, 2012 ª2012 Elsevier Inc. 513
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Figure 2. Ectopic Expression of IL-27 Increases Treg Cell Expression of T-bet and CXCR3
(A–D) WT mice were injected by hydrodynamic tail vein delivery control (eGFP) or IL-27 minicircles (IL-27MC) and examined 4 weeks after treatment.
(A and B) T-bet (A) and CXCR3 (B) expression by Treg cells (gated on LIVE/DEAD Fixable Aqua Dead Cell marker, CD4+, Foxp3+ cells) and non-Treg T cells
(gated on LIVE/DEAD Fixable Aqua Dead Cell marker, CD4+, Foxp3 cells) isolated from the spleen were measured by flow cytometry.
(C and D) The percentage of Treg (C) and non-Treg (D) cell expression of T-bet and CXCR3 from individual mice. Data are representative of two independent
experiments with five mice per group. Statistical significance was determined by a two-tailed unpaired Student’s t test. Error bars indicate SEM. *p < 0.05, **p <
0.01. See also Figure S2.
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IL-27 Promotes Th1 Treg Cellsorally with T. gondii and analyzed their Treg cell populations. In
these experiments, the Foxp3 CD4+ effector (CD44hi) T cells
from WT or Il27/ mice expressed equivalent levels of T-bet
or CXCR3 (Figure 4A), but several Treg cell populations from
the Il27/ mice had reduced expression of T-bet, CXCR3, and
IL-10 (Figures 4B–4D; Figure S3F). Despite the systemic levels
of IFN-g and IL-12 (Figure 4E), a striking deficiency in T-bet+
CXCR3+ Treg cells was observed in the gut-associated lymphoid
tissue (GALT). In contrast, at peripheral sites such as the spleen,
these populations were not affected, consistent with the
increased expression of IL-27 observed in the gut versus the
spleen (Figure 3F). To determine whether IL-27 had a similar
role in other models, we infected WT or Ebi3/ mice with
Leishmania major or Salmonella typhimurium. These infections
also induced T-bet+ CXCR3+ Treg cells and in the absence of
IL-27, there was a defect in Treg cell expression of T-bet and
CXCR3 (Figures S3G and S3H). These results indicate a domi-
nant role for IL-27 in Treg cell polarization at sites of ongoing
Th1 cell responses.
Acute Lethality in T. gondii-Infected Il27–/– Mice Is
Rescued by Transfer of Treg Cells
To test whether the infection-induced CD4+ T cell-mediated
pathology in Il27/ mice could be ameliorated by Treg cells,
we infected WT and Il27/ mice with T. gondii, and at days 4,
7, and 10 postinfection provided mice with iTreg cells. This
regimen was chosen because Treg cell homeostasis is altered
during T. gondii infection as a result of increased Treg cell death
(Oldenhove et al., 2009), and repeated transfer of Treg cells alle-
viates inflammation in several models (Darrasse-Je`ze et al.,
2009; Grainger et al., 2010; Mor et al., 2007; Zheng et al.,
2006). Although infected Il27/ mice developed immune
pathology and succumbed to acute infection, those that514 Immunity 37, 511–523, September 21, 2012 ª2012 Elsevier Inc.received IL-27-conditioned Treg cells, or Treg cells generated
under neutral conditions, were rescued (Figure 4F). This effect
was associated with reduced numbers of effector T cells and
decreased serum alanine aminotransferase (Figures S4A–S4C),
suggesting that the transferred Treg cells limit effector cell
expansion and pathology. Compared with the endogenous
Treg cells, the Treg cells transferred into infected Il27/ mice
expressed higher levels of IL-10, IFN-g, T-bet, CXCR3, and
CTLA-4 and had increased proliferation as measured by Ki-67
(Figures S4D–S4G). When Treg cells were transferred into naive
mice, Foxp3 expression was not retained, whereas in infected
mice transferred cells sustained Foxp3 expression at sites of
inflammation (Figure S4G), suggesting that environmental cues
maintain these cells. Moreover, when adoptive transfer experi-
ments were conducted with Treg cells generated from Il10/
mice, recipient animals succumbed rapidly to infection, indi-
cating that IL-10 is required for Treg cell-mediated rescue of
Il27/ mice (Figure 4F). These data establish that Treg cells
can ameliorate the pathology observed in the Il27/ mice and
are consistent with a model in which Il27/ mice infected with
T. gondii have an underlying Treg cell defect, which contributes
to the development of immune pathology. Nevertheless, these
data have to be interpreted cautiously. The ability of neutral
Treg cells to rescue these mice may be attributed to their
eventual acquisition of T-bet and CXCR3 noted after TCR
stimulation (Figure S1E). However, because neutral Treg cells
could promote the survival of Il27/ mice, Il27ra/ and
Ifngr1/ iTreg cells were generated and transferred into infected
Il27/mice to determine whether expression of these receptors
was required for protection (Figure S5A). These studies revealed
that both cytokine receptors were required to rescue Il27/
mice and suggest that although IL-27 is required for Treg cell
expression of T-bet and CXCR3 at the sites of inflammation,
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Figure 3. Treg Cells Have a Th1 Cell Phenotype and Suppress Effector T Cell IFN-g Production during Toxoplasmosis
(A and B) Treg cells (gated on LIVE/DEAD Fixable Aqua Dead Cell marker, TCR-b+, CD4+, Foxp3+) were isolated from the lamina propria lymphocytes (LPLs) of
naive or T. gondii-infectedWTmice and analyzed for their expression of IFN-g after restimulationwith PMA and ionomycin in the presence of Golgi inhibitors (A) or
directly ex vivo without restimulation from Vert-X IL-10-eGFP reporter mice (B).
(C) LPL Treg cells from WT T. gondii infected mice co-express IFN-g and IL-10 after restimulation with PMA and ionomycin in the presence of Golgi inhibitors.
(D) T-bet and CXCR3 expression by Treg cells isolated from the mesenteric lymph nodes (mLN) of naive (shaded histogram) or T. gondii-infected mice (solid line).
(E) The mean percentage ± SEM of T-bet and CXCR3 expressing Treg cells in the mLN of naive and infected mice are depicted. Data are representative of >5
experiments; n = 5. Statistical significance was determined by a two-tailed unpaired Student’s t test. *p < 0.05.
(F) Cells were isolated from the spleen and LP of naive and infected mice and incubated with Golgi inhibitors for 6–8 hr. IL-12p40 and IL-27p28 expression was
measured in LIVE/DEAD Fixable Aqua DeadCell marker, CD19, B220, NK1.1, and CD3 cells that are CD11b+CD11cint (top panel) or CD11chi MHCClass-
IIhi (bottom panel).
(G) WT and DEREGmice were infected with T. gondii and treated with diphtheria toxin on days 2–9 of infection. On day 9 postinfection, T cells were isolated from
the lamina propria and spleen by CD90.2 expression and cultured with media alone, dendritic cells, or dendritic cells pulsed with soluble Toxoplasma antigen
(STAg). Treg cells (gated on LIVE/DEAD Fixable Aqua Dead Cell marker, TCR-b+, CD4+, and Foxp3+ cells) were stained for T-bet and IFN-g expression. These
data are representative of three experiments, nR 3 per experiment. See also Figure S3.
Immunity
IL-27 Promotes Th1 Treg Cells
Immunity 37, 511–523, September 21, 2012 ª2012 Elsevier Inc. 515
WT Il27-/-
500
1500
0
2500
WT Il27-/-
2500
0
5000
WT Il27-/-
250
750
0
1250
WT Il27-/-
250
750
0
1250
Lamina Propria
**
Peyer’s Patches
*
mLNSpleen
T-
be
t M
FI
C
WT Il27-/-
1000
0
2000
WT Il27-/-
2500
0
5000
WT Il27-/-
2000
0
4000
500
WT Il27-/-
0
1000
Lamina Propria
*****
Peyer’s Patches
*
mLN
*
Spleen
C
X
C
R
3 
M
FI
D
IL-12p40
0
5
15
25
WT Il27-/-
ng
/m
L
pg
/m
L
IL-27p28
0
20
40
60
WT Il27-/-
IFN-γ
ng
/m
L
0
2.5
7.5
12.5
WT Il27-/-
E
F
S
ur
vi
va
l (
%
)
Days post-infection
0 10 20 30
0
25
50
75
100
Il27-/- + TH1 Treg cells
WT
WT+ TH1 Treg cells
Il27-/-
Il27-/- + Il10-/- Treg cells
Il27-/- + Neutral Treg cells
A Naive non-Treg cells
CD4
T-
be
t
66.4
40
9
53.1
26
1
C
X
C
R
3
Infected  non-Treg cells
90.1
11
88
76.1
59
5
38.5
94
4
27.1
73
0
T-
be
t
70.5
13
62
46.6
99
5
C
X
C
R
3
WT
Il27-/-
B
92.6
81
54
37.5
68
T-
be
t
93
23
81
1
41.3
90
7
C
X
C
R
3
C
X
C
R
3
36.7
89
5
32.4
79
3
CD4
T-
be
t
38.2
83
28
20
.3
Naive Treg cells Infected Treg cells
WT
Il27-/-
Figure 4. Th1 TregCell Development duringT. gondii Infection Is IL-27-Dependent and iTregCells CanRescueAcute Pathology in Il27–/–Mice
(A–D) Cells were isolated from the spleen,mLN, Peyer’s patches, and LPL of naive and T. gondii-infectedWT and Il27/mice. T-bet and CXCR3 expression were
measured on non-Treg CD4+ T cells (gated on LIVE/DEAD Fixable Aqua Dead Cell marker, TCR-b+, CD4+, and Foxp3 cells; A) and Treg cells (gated on LIVE/
DEADFixable AquaDeadCellmarker, TCR-b+, CD4+, andFoxp3+cells; B); Peyer’s patches are shown. TheMFI of Treg cell T-bet (C) andCXCR3 (D) expression
from individual mice are shown for all tissues. Data are representative of >5 experiments. Statistical significance was determined by a two-tailed unpaired
Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001.
(E) Levels of IL-27p28, IL-12p40, and IFN-g were measured in the serum of WT and Il27/ mice on day 9 postinfection by ELISA. Error bars indicate SEM.
(F) WT and Il27/ mice were infected intraperitoneally with T. gondii and received PBS or 2 to 4 3 106 WT Treg cells cultured in neutral conditions (two
experiments, n = 5), WT Treg cells cultured with IL-27 (Th1 Treg cells) (four experiments, n = 10), or Il10/ Treg cells cultured with IL-27 (two experiments, n = 8).
Mice received Treg cells on day 4, 7, and 10 postinfection. Percent survival is represented with Kaplan-Meier analysis. See also Figures S3 and S4.
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Figure 5. IFN-g Promotes the Th1 Treg Cell Phenotype in the Periphery, but Not Sites of Inflammation
(A–D) Mice were infected with T. gondii and treated with anti-IFN-g or control antibodies (rat IgG) on day 3, 5, 7, and 9 postinfection.
(A) On day 10, cells were isolated from the spleen and LPL of naive and infected mice and T-bet and CXCR3 expression by Treg cells were measured by flow
cytometry (gated on LIVE/DEAD Fixable Aqua Dead Cell marker, TCR-b+, CD4+, and Foxp3+ cells).
(B) Plots depict theMFI of T-bet and CXCR3 expression by Treg cells. Statistical significance was determined by a two-tailed unpaired Student’s t test. Error bars
indicate SEM. *p < 0.05, **p < 0.01.
(C) Spleen and LPL cells were restimulated with PMA and ionomycin in the presence of Golgi inhibitors and analyzed for IL-10 and IFN-g expression within Treg
cells.
(D) Plots depict the frequency of Treg cells expressing IL-10 and IFN-g after restimulation. Plots are representative of two experiments, n = 5. See also Figure S5.
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mice.
Differential Effects of IFN-g and IL-27 on Treg Cells
Although our studies have focused on the effects of IL-27 on Treg
cells, our own data (Figure S5A) indicate that IFN-g also has
a role in these events, and Treg cells from the spleens (but not
the gut) of infected mice have high expression of IFN-gR1 and
IFN-gR2 (Figure S5B). To directly address the role of IFN-g in
generating Treg cell diversity during toxoplasmosis, we treated
infected mice with a-IFN-g starting 3 days after infection.
Neutralization of IFN-g did not alter basal expression of T-bet
or CXCR3 in Treg cells from naive mice, but in infected mice
there was a significant decrease in levels of T-bet and CXCR3
in the spleen (Figures 5A and 5B). In contrast, there was no effect
of IFN-g depletion on Treg cell expression of T-bet and CXCR3 in
the GALT of infected mice (Figures 5A and 5B). Furthermore,
after restimulation, Treg cell production of IL-10 and IFN-g was
not lower in the spleen or the LPL in the absence of IFN-g,Imdemonstrating that IFN-g is not critical for Treg cell production
of these cytokines (Figures 5C and 5D). These results suggest
that the effects of IFN-g are prominent at peripheral sites,
whereas the effects of IL-27 are most apparent at the local sites
of inflammation.
To better understand the differential effects of IFN-g and IL-27
on Treg cells, we performed a series of studies to directly
compare their signaling and effects on Treg cell differentiation
and transcriptional responses. When Treg cells were stimulated
with IFN-g or IL-27, both cytokines induced pSTAT1 but only
IL-27 activated STAT3 and STAT5 (Figures 6A and 6B). However,
although the kinetics of pSTAT1 signaling was similar, IL-27
induced markedly elevated amounts of pSTAT1 (Figures 6A
and 6B). Next, the effects of IFN-g and IL-27 on Treg cells
were compared in vitro. By day 5 of iTreg cell culture, IFN-g
and IL-27 treatment resulted in increased T-bet and CXCR3
expression but IL-27 had a more profound effect (Figures 6C–
6E). In nTreg cell cultures, treatment with IL-27 resulted in higher
T-bet expression compared to IFN-g treatment, although themunity 37, 511–523, September 21, 2012 ª2012 Elsevier Inc. 517
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Figure 6. IFN-g and IL-27 Have Distinct Effects on Treg Cells
(A) nTreg cells were isolated from naive mice and treated with media alone, IFN-g, or IL-27. Levels of pSTAT1, pSTAT3, and pSTAT5 were measured over time by
flow cytometry. Results were normalized to media control. Plots are representative of two experiments, n = 2.
(B) iTreg cells were generated under neutral conditions for 7 days and stimulated as in (A).
(C–E) iTreg cells were generated under neutral conditions or with IL-27 or IFN-g (without blocking antibodies to IFN-g and IL-4) and T-bet and CXCR3 expression
was measured on day 5 (C) in replicate cultures (D) and over time (E). Plots are representative of three experiments. Statistical significance was determined by
a two-tailed unpaired Student’s t test. Error bars indicate SEM. **p < 0.01, ***p < 0.001.
(F andG) NTreg cells were isolated and cultured under neutral conditions or treatedwith IFN-g or IL-27 andmonitored for T-bet andCXCR3 expression on day 5 of
culture (F) and over time (G). Plots are representative of three independent experiments. See also Figure S6.
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Perhaps the most notable difference was that although both
IL-27 and IFN-g-conditioned Treg cells produced IFN-g, only
the IL-27-conditioned Treg cells made IL-10 (Figure S6A).
Finally, expression profiling of Treg cells generated during
IL-27 and IFN-g treatment was performed. To obtain sufficient
cells for analysis and ensure a uniform starting population, we
generated iTreg cells under neutral conditions and then cultured
them in neutral, IFN-g, or IL-27 conditions for 10 and 48 hr.518 Immunity 37, 511–523, September 21, 2012 ª2012 Elsevier Inc.Microarray analysis identified 185 genes that were differentially
expressed compared to neutral controls, either early (10 hr) or
late (48 hr) after treatment (p % 0.05). Hierarchical clustering
identified groups of genes that showed similar expression
patterns across the three treatments and two time points and re-
vealed three distinct clusters that are regulated in different ways
by IL-27 compared to IFN-g (Figure 7; Figure S6B). Cluster 1 (23
genes) was enriched for metabolic functional categories and is
suppressed by IL-27 while remaining relatively unchanged in
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Figure 7. IL-27 Induces a Gene Expression Profile in Treg Cells that Is Distinct from the Profile induced by IFN-g
(A–F) iTreg cells were cultured under neutral conditions for 7 days, harvested, and then exposed to neutral, IL-27, or IFN-g Treg cell culture conditions for 10 or
48 hr. mRNA was isolated and microarray analysis was performed as described in the Experimental Procedures. Hierarchical clustering analysis was performed
on genes that were differentially regulated 1.5-fold or greater, compared to neutral conditions, by either IL27 or IFN-g after 10 hr or 48 hr culture, p < 0.05. Three
clusters of genes are shown as heatmaps. The following are shown in these panels: (A) genes downregulatedmost strongly by IL-27; (C) genes upregulated by IL-
27 but not IFN-g; and (E) genes induced by both cytokines, but to a greater degree by IL-27. The heatmap color indicates log2 expression value. Clusters are also
represented by line graphs showing the fold changes in gene expression (B, D, and F). Each line shows gene expression changes for a single gene. Several genes
had more dramatic changes in expression at either the 10 hr or 48 hr time points and thus were grouped as subgroup 1 ‘‘early’’ and subgroup 2 ‘‘late,’’
respectively. See also Figure S6.
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IL-27 Promotes Th1 Treg Cellsthe presence of IFN-g (Figures 7A and 7B). In contrast, cluster 2
(17 genes) is induced by IL-27, but not IFN-g (Figures 7C and 7D).
This cluster contains two subgroups: the first includes ten genes
induced early by IL-27 but were either not induced by IFN-g or
weakly induced at 10 hr and were not sustained to 48 hr (Fig-
ure 7D). This subgroup includes Tbx21, Il10, Lag3, Ccr5,
Il12rb1, and Il12rb2, highlighting a group of genes involved in
T cell activation that are coordinately regulated by IL-27. TheImsecond subgroup includes seven genes that are not affected
early by either cytokine but are induced at 48 hr by IL-27 (Fig-
ure 7D). Finally, a third cluster of 45 genes was identified that
is enhanced by IL-27 and IFN-g, but for which IL-27 was
a more potent inducer (Figures 7E and 7F). This cluster includes
many canonical STAT1 target genes, further demonstrating the
ability of IL-27 to act as an activator of STAT1-dependent
gene transcription in Treg cells. Thus, although IFN-g andmunity 37, 511–523, September 21, 2012 ª2012 Elsevier Inc. 519
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IL-27 Promotes Th1 Treg CellsIL-27 can give rise to a phenotypically similar population of Treg
cells, these two cytokines have distinct transcriptional effects on
Treg cells that are indicative of a more complex biology and may
reflect the regional effects observed in vivo.
DISCUSSION
In the last decade, there has been a growing appreciation of the
inhibitory properties of IL-27 in the setting of autoimmunity and
inflammation (Stumhofer and Hunter, 2008; Yoshida and Miya-
zaki, 2008). Indeed, studies with Il27ra/ mice infected with
T. gondii have identified a role for IL-27 in limiting the production
of IL-2, antagonizing Th17 cells and promoting effector cell
production of IL-10 (reviewed in Hall et al., 2012). In early studies,
it did not appear that the enhanced inflammation observed in
thesemicewas a consequence of a defective Treg cell response,
given that IL-27 did not alter Treg cell activity in suppressor
assays, nor are there any overt differences in the frequency of
Treg cell populations in Il27ra/ mice (Villarino et al., 2003 and
this work). The data presented here highlight that the ability of
IL-27 to promote a specialized population of Treg cells contrib-
utes to its suppressive activities in multiple experimental models
and indicate that this is one of the many pathways that limit overt
T cell-mediated inflammation in this model (Aliberti et al., 2002;
Bhadra et al., 2011; Buzoni-Gatel et al., 2001; Gazzinelli et al.,
1996).
It has been suggested that Treg cells have a limited role during
toxoplasmosis (Couper et al., 2009; Jankovic et al., 2007), but
the Treg cell depletion studies presented here indicate that these
cells are relevant. The finding that Treg cell transfers can reverse
the infection-induced pathology observed in Il27/ mice
provides additional support for the idea that Treg cells are oper-
ational during toxoplasmosis. However, these transfer experi-
ments have to be interpreted carefully, and they illustrate how
understanding the mechanisms by which adoptively transferred
Treg cells suppress in vivo remains elusive. Although our system
clearly shows that Treg cells need to express Il27ra, Ifngr1, and
Il10 to rescue Il27/ mice, it is unclear how these signals are
integrated. Because the transfer of activated Treg cells can
rescue the Il27/ mice, it implied that signals other than IL-27
(such as IFN-g or TCR stimulus) could be important. However,
given these data, if IFN-g or TCR were sufficient to contribute
to Treg cell function in vivo, we would expect that it could
contribute to protection upon adoptive transfer of Il27ra/
Treg cells, which is not the case. We cannot rule out a role for
IL-27Ra independently of IL-27 and/or gp130 given that the
IL-27Ra has the capacity to signal via JAK1-STAT1 indepen-
dently of gp130 (Pradhan et al., 2007; Takeda et al., 2003).
Moreover, the IL-27Ra is also a component of the receptors
for cytokine-like factor-1 (CLF-1) and humanin, and there is an
alternatively spliced form of IL-27Ra that may be involved in
trans-signaling (reviewed in Hall et al., 2012). Thus, it remains
to be determined whether the IL-27-independent properties of
IL-27Ra play a role in Treg cell function during infection. Alterna-
tively, our mRNA expression data (Figure S6C) suggest the
possibility that Treg cells may also produce IL-27, implying that
autocrine signaling through IL-27Ra may be important for the
function of Treg cells. Nevertheless, these observations raise
fundamental questions about whether this Th1 cell-like Treg520 Immunity 37, 511–523, September 21, 2012 ª2012 Elsevier Inc.cell population is derived from nTreg cells or iTreg cells, whether
these cells are specific for Toxoplasma, and how IFN-gR1, IL-
27Ra and IL-10 contribute to their function in vivo.
Although the emphasis of these studies has been on the role of
IL-27 during infection, our findings imply that IL-27 and IFN-g act
in distinct sites during infection, perhaps a consequence of local
differences in the cytokine environment. However, despite the
systemic elevation of IFN-g present in infected Il27/ mice,
there is still a defect in the generation of T-bet+ Treg cells at sites
of inflammation, indicating a critical role for IL-27 in mediating
Treg cell expression of T-bet and CXCR3. Additionally, the ability
of IL-27, but not IFN-g, to promote the expression of IL-10 in Treg
cells highlights distinct functions of these cytokines.
The observation that in naive mice, only a subset of Treg cells
expresses the IL-27 and IFN-g receptors raises the question of
whether these Treg cells subsets are ‘‘hard-wired’’ to deal with
specific types of inflammation. Indeed, little is known about the
heterogeneity in Treg cell expression of cytokine receptors and
whether this predicts their capacity to influence distinct types
of inflammation. In the context of trying to understand Treg cell
heterogeneity, microarray analysis of Treg cells isolated from
different anatomical sites revealed that distinct subsets of Treg
cells exist with nonoverlapping transcriptional profiles (Feuerer
et al., 2009; Feuerer et al., 2010). Similarly, when we compared
the transcriptional profiles of Treg cells treated with IFN-g and
IL-27, these data revealed at least three clusters of genes that
are differentially regulated. The largest cluster consists of many
known STAT1 target genes, reinforcing the notion that IL-27 is
a potent inducer of STAT1-mediated transcription. It is unclear
how the specific STAT1 genes that we have identified as IL-27
targets might contribute to Treg cell activity, but these data will
aid in the selection of candidates for future studies of Treg cell
function. In addition, we have identified a subset of genes that
are specifically induced by IL27 but not IFN-g, providing candi-
datemediators for IL-27-specific Treg cell function. For instance,
we found that Ly6c1 is strongly induced by IL-27. Although its
role in Treg cell biology has not been addressed, it has been
implicated in the function and homing of effector T cells (Jaak-
kola et al., 2003; Marshall et al., 2011). These data also highlight
that examining a select few phenotypic markers (such as T-bet
and CXCR3), may oversimplify the complex heterogeneity that
exists in Treg cells during infection.
Many studies have defined how factors such as IL-2, TGF-b,
and Foxp3 have a prominent role in the homeostasis and func-
tion of Treg cells (Apostolou et al., 2008; Bayer et al., 2007; Fon-
tenot et al., 2005). Although there is good evidence that an
ongoing immune response can limit Treg cell function and differ-
entiation (Caretto et al., 2010; Mantel et al., 2007; Pasare and
Medzhitov, 2003; Wei et al., 2007), recent reports indicate that
by utilizing the same transcription factors as their effector coun-
terparts, Treg cells may become specialized to operate in
distinct inflammatory environments (Chaudhry et al., 2009;
Koch et al., 2009; Zheng et al., 2009; Lu et al., 2010). These find-
ings have led to models in which environmental cues promote
the development of specialized Treg cell subsets. The finding
that IL-27 promotes a specialized subset of Treg cells delineates
a unique pathway by which they are influenced by the inflamma-
tory environment. These findings may be directly relevant to
human disease, and it is notable that a loss of Treg cells has
Immunity
IL-27 Promotes Th1 Treg Cellsbeen observed in human patients with inflammatory bowel
disease (IBD) (Eastaff-Leung et al., 2010). A recent report linked
a polymorphism in the IL-27p28 loci, associated with reduced
production of IL27 transcripts, to increased susceptibility to
IBD (Imielinski et al., 2009). The finding that IL-27 can profoundly
influence Treg cell populations in the gut may offer a partial
explanation for the susceptibility of these particular patients
to IBD.
EXPERIMENTAL PROCEDURES
Mice and Infection
Il27/ mice were generated by Lexicon Pharmaceuticals, Inc. Wild-type
C57BL/6J (WT), Il10/, Swiss Webster and CBA/CaJ mice were purchased
from Jackson laboratory. Tbx21/ and CD4-Cre 3 Eomesfl/fl mice were
provided by S. Reiner. Stat1/ mice were purchased from Taconic labs.
Foxp3GFP reporter mice were obtained from V. Kuchroo, and Vert-X IL-10-
eGFP (C57BL/6- Il10tm1.1Karp) reporter mice (Madan et al., 2009) were
provided by C. Karp and bred in our facility. All mice were housed in a
specific-pathogen free environment at the University of Pennsylvania School
of Veterinary Medicine in accordance with federal guidelines and with
approval of the Institutional Animal Care and Use Committee. The ME49 strain
of T. gondii was maintained in Swiss Webster and CBA/CaJ mice and used
as a source of tissue cysts for oral (100 cysts) or i.p. (20 cysts) infections.
For Treg cell depletion experiments, WT or DEREG mice (Lahl et al., 2007)
were infected orally with 10 cysts of ME49. Two days after infection, mice
were injected with diphtheria toxin (Calbiochem) in endotoxin-free PBS. One
microgram of toxin was injected i.p. for 7 consecutive days. For the depletion
of IFN-g, WT mice were infected orally and starting at day 3 postinfection
treated with 2 mg anti-mouse IFN-g (clone XMG1.2, BioXcell) or ratIgG control
(Sigma) every 2 days.
Regulatory T Cell Differentiation
For iTreg cells, CD4+ CD25 or Foxp3GFP cells were separated by FACS or
MACs sorting (Miltenyi). Cells were rested for 30 min in complete RPMI
(cRPMI) media (1% penicillin/streptomycin, 2 mM L-glutamine, 10% fetal
bovine serum, 0.1% beta-mercaptoethanol, 1% nonessential amino acids,
1 mM sodium pyruvate, and 20 mM HEPES) (GIBCO). Cells were cultured at
1 3 106 cells/mL in aCD3-coated (1 mg/mL; clone 145-2C11; eBioscience)
96-well U-bottom plates (Costar) in cRPMI containing aCD28 (1 mg/mL; clone
37.51; eBioscience), recombinant human (rHu) TGF-b2 (5 ng/mL, eBio-
science), with or without rHu IL-2 (100U/mL; Proleukin), anti-IFN-g
(10 mg/mL; clone XMG1.2), anti-IL-4 (10 mg/mL; clone 11B11) blocking anti-
bodies, and recombinant mouse (rMu) IL-27 (50ng/mL; Amgen), with or
without rMu IFN-g (50 ng/mL; R&D). Media was added every 2 days with initial
cytokines and neutralizing antibodies. For nTreg cells, sorted Foxp3+ cells
were cultured on plate-bound aCD3 in media containing aCD28, 100 U/mL
rHu IL-2, 5 ng/mL rHu TGF-b2, with or without neutralizing antibodies to
IFN-g, or IL-4, with rMu IL-27 or rMu IFN-g.
Isolation and Flow Cytometric Analysis of Immune Populations
Single-cell suspensions from the spleens, mesenteric lymph nodes (mLNs),
and Payer’s patches were prepared with standard methods. For the analysis
of lamina propria lymphocytes (LPLs), small intestines were collected in PBS
at 4C and cut longitudinally, and fecal contents were removed in PBS. Epithe-
lial cells were stripped (5 mM EDTA and 1 mM DTT) in cRPMI, digested
(0.16U/mL Liberase TL) (Roche) for 30 min at 37C, and processed for
lymphocytes.
Cells were stained in FACS buffer (0.5% BSA, 2mM EDTA in PBS) with Fc
block (2.4g2, BD) containing LIVE/DEAD Fixable Aqua Dead Cell marker
(Invitrogen), with the following surface antibodies: CD4 Percp-Cy5.5 (RM4-5,
eBioscience), CD8a PE-Texas Red (53-6.7, Abcam), CD44 PE-Cy7 (IM7,
eBioscience), CD62L APC-eFluor780 (MEL-14, eBioscience), TCR-b Alexa
Fluor700 (H57597, BioLegend), CD3 eFluor450 (17A2, eBioscience), CD25
APC-eFluor780 (PC61.5, eBioscience), CXCR3 PE and APC (220803, R&D),
and PE-Cy7 (CXCR3-173, BioLegend). All intracellular staining was doneImwith the Foxp3/transcription factor staining buffer set (eBioscience) for
Foxp3 Alexa Fluor488 and eFluor450 (FJK-16 s, eBioscience), T-bet
eFluor660, and FITC (4B10, eBioscience and BioLegend, respectively), Ki-67
Alexa Fluor488 and Alexa Fluor647 (B56, BD), CTLA-4 PE (UC10-4F10-11,
BD), and EOMES PE (Dan11mag, eBioscience).
For detecting cytokine production, isolated cells were cultured in cRPMI in
six replicates at 1 3 106 cells/mL in a 96-well U-bottom plate, with PMA and
ionomycin for 5 hr with Brefeldin A (Sigma) and monensin (BD) Golgi inhibitors.
Cells were rinsed, stained for surfacemarkers at 4C, and fixed with 4%PFA in
PBS for 10min at RT. Intracellular cytokines were detected by staining in FACs
buffer containing 0.5% saponin (Sigma), IL-10 APC (JES5-16E3, eBioscience),
IFN-g PE-Cy7 or Percp-Cy5.5 (XMG1.2, eBioscience), and Foxp3. Intracellular
IL-10 was detected ex vivo with Vert-X IL-10-eGFP reporters and antibodies
for GFP (polyclonal rabbit anti-GFP, eBioscience and FITC-conjugated rat
anti-rabbit Jackson Immunoresearch) with staining for Foxp3.
STAT Phosphorylation Assays
nTreg cells were isolated ex vivo, and iTreg cells were generated in vitro.
Before stimulation, cells were washed in 0.5% BSA RPMI and rested at 4C
for 20 min. WT and Il27ra/ Treg cells were incubated with 50 ng/mL rMu
IL-27, 50 ng/mL rMu IL-10 (R&D), and 50 ng/mL rMu IFN-g for 20 min or
over various time points at 37C in the presence of LIVE/DEAD Fixable
Aqua Dead Cell marker and then immediately fixed on ice in 4% PFA for
20 min. After PBS rinse, cells were permeabilized in 90% methanol on ice
for 1 hr or stored at 20C overnight. Staining was performed in Fc block
with BD PhosFlow antibodies to pSTAT1 (pY701) PE, pSTAT3 (pY705) Alexa
Fluor488, and pSTAT5 (pY694) Alexa Fluor647 with antibodies to T-bet,
Foxp3, TCR-b, CD4, and CD25.
Production and Delivery of IL-27 Minicircle DNA
The p2øC31.RSV.hAAT.bpA plasmid was provided by Z.-Y. Chen (Stanford
University, Stanford, CA), and the vector was modified to include unique 50
PmeI and 30 PacI restriction sites flanking hAAT for directional cloning of
cDNAs. PCR amplification was used for placing 50 PmeI and 30 PacI cloning
sites on the linked mIL-27 cDNAs, which were ligated with the modified mini-
circle plasmid. Minicircle DNA was produced as described (Chen et al., 2005)
with minor modifications for overnight cultures. Terrific broth containing 100
ug/ml ampicillin was inoculated and incubated for 18 hr and shaken at
270 rpm. Endotoxin free QIAGEN megaprep kits were used for DNA purifica-
tion, which was resuspended in endotoxin-free Tris EDTA. Minicircle DNA
was dialyzed in Midi MWCO 3.5 kDa tubes overnight against Tris EDTA and
minicircle DNA was verified by restriction digestion and sequencing. For
a hydrodynamics-based transfection procedure (Liu et al., 1999), 20 mg of
minicircle DNA in 2 ml of Ringer’s solution was administered via tail vein injec-
tion within 5–8 s.
ELISAs and LP Dendritic Cell Intracellular Cytokine Detection
IL-27p28 (DuoSet, R&D), IL-12p40 (C17.8 and C15.6 biotin), and IFN-g (AN18
and R4-6A2 biotin, eBioscience) weremeasured by ELISA. For detecting intra-
cellular IL-27p28 and IL-12p40, LP dendritic cells (LpDCs) were enriched with
the 1-Step 1.077/265 gradient (Accurate Chemical & Scientific Corp.), incu-
bated for 6–8 hr at 37C in the presence of Brefeldin A and Monensin, surface
stained in Fc block including LIVE/DEAD Fixable Aqua Dead Cell marker for
MHC Class II I-A I-E Alexa Fluor 700 (M5/114.15.2, BioLegend), CD11c
PE-Cy7 (N418, eBioscience), CD11b PerCP-Cy5.5 (M1/70, eBioscience),
NK1.1 Pacific Blue (PK136, BioLegend), CD3 eFluor450, and CD19 eFluor450
(1D3, eBioscience), and fixed with 4% PFA. Cytokines were detected by
staining for IL-12p40 PE (C15.6, BD) and IL-27p28 Alexa Fluor 647 (clone
MM27-7B1, BioLegend) for 30 min in 0.5% Saponin.
Adoptive Transfer Studies
WT or Il27/ animals were infected intraperitoneally with 20 cysts ME49
T. gondii and monitored for morbidity. Neutral Treg cells were generated
from naive WT CD25 CD4+ T cells or Th1 Treg cells were generated from
naive WT or Il10/ CD4+ CD25 T cells. At day 4 postinfection, mice received
either i.v. PBS or 2 to 43 106 Treg cells, followed injections of Treg cells on day
7 and 10.munity 37, 511–523, September 21, 2012 ª2012 Elsevier Inc. 521
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Enrichment Analysis
For whole-genome-expression microarray, iTreg cells were generated under
neutral conditions for 7 days to ensure a homogeneous starting population of
Treg cells. Cells were harvested and then exposed to neutral, IL-27, or IFN-g
Treg cell culture conditions for 10 or 48 hr. RNA was isolated with RNeasy
Plus (QIAGEN) and quality was assessed by Bioanalyzer (Agilent). Biotin-
labeled complementary RNA (cRNA) was made with the Illumina TotalPrep
RNA amplification kit. An Illumina MouseWG-6 version 2 expression beadchip
was hybridized with cRNA from three biological replicates and scanned on
a beadscan unit. Data were quantile normalized and differential expression
analysis was carried out with GenomeStudio v1.8 software (Illumina). Genes
were considered differentially regulated by IL-27 or IFN-g if expression level
changed R1.5-fold compared to neutral controls with a corresponding diff-
score R13 or %13 (equivalent to p % 0.05). Hierarchical clustering (Eisen
et al., 1998) and heat map tools available on GenePattern (Reich et al., 2006)
were used for analyzing and displaying microarray data. Gene ontology (GO)
enrichment analysis was done with the Database for Visualization and Integra-
tive Discovery (DAVID) (Dennis et al., 2003) with enrichment defined relative to
entire microarray. Only GO terms shared by three or more genes and that had
an enrichment p value of < 0.05 were considered for analysis.
Statistical Analysis
Statistical significance was determined by a two-tailed unpaired Student’s t
test. Error bars indicate the standard deviation of the mean; *p < 0.05, **p <
0.01, and ***p < 0.001. Percent survival is represented with Kaplan-Meier
analysis.
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